US 10875903
Bifunctional fusion proteins to inhibit angiogenesis in tumor microenvironment and to activate adaptive immune responses and the genes and uses thereof
granted A61KA61K38/00A61P
Quick answer
US patent 10875903 (Bifunctional fusion proteins to inhibit angiogenesis in tumor microenvironment and to activate adaptive immune responses and the genes and uses thereof) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CHINA PHARMACEUTICAL UNIVERSITY
- Grant date
- Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00, A61P37/02